当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第18期
编号:11620648
肿瘤厌氧靶向双自杀基因治疗系统pH2/CD,pH2/UPRT的构建(3)
http://www.100md.com 2008年7月22日 《中国实用医药》 2008年第18期
     胞嘧啶脱氨酶(CD)和5-氟-胞嘧啶(5-FC)系统(CD/5-FC)是自杀基因的原型,低毒的5-FC可以被CD代谢为抗肿瘤药5-FU。全身给药的5-FC到达肿瘤,而靶向到肿瘤局部的CD基因转化5-FC至5-FU将会杀死肿瘤细胞,但对全身的毒性则大大降低。因为很多肿瘤对5-FU产生抗性,所以构建(CD/5-FC)的协同杀伤机制将可能克服其抗药性,并明显增强CD/5-FC 肿瘤自杀基因治疗系统的效力。

    5-FU杀灭肿瘤细胞的机制包括被进一步代谢为5-FdUMP,5-FdUTP和5-FUTP,这些分子可以干扰细胞RNA 和DNA 合成[10-11]。UPRT 是一种来源于原核生物的酶,它可以非常有效的催化5-FU生成5-FdUMP,使得5-FdUMP,5-FdUTP,和5-FUTP大量增加,从而增强5-FC/CD系统对肿瘤细胞的杀伤作用。所以构建CD 和UPRT相结合的双自杀基因系统将可能显著增强该系统的肿瘤杀伤能力[12-16]
, http://www.100md.com
    当厌氧菌被重组为携带有高效表达自杀基因的质粒时,厌氧菌的肿瘤靶向性将使得它们在肿瘤组织聚集,而原药5-FC将在肿瘤组织内部高效地被自杀基因CD/UPRT转化为细胞毒性的抗肿瘤药物。婴儿双歧杆菌是一种非致病性的厌氧菌株。本实验室在先前的研究中已经证明其对实体瘤的靶向性[1],并构建出携带有pGEX-1LamdaT/CD和pGEX-1LamdaT/UPRT的婴儿双歧杆菌,并且表现出体外对肿瘤的杀伤作用,但由于pGEX-1LamdaT是大肠杆菌表达载体,重组至厌氧菌中其蛋白质的表达效率并不令人满意[16-17]

    质粒pH2是一个厌氧菌特异性质粒,带有一个分泌性基因表达系统,可以在乳酸菌和双歧杆菌中高效率表达分泌型蛋白质[3]。我们最终成功的构建了pH2/CD和pH2/UPRT婴儿双歧杆菌分泌性自杀基因表达系统,并已获得CD,UPRT基因mRNA水平的良好表达。在体外杀伤鼠黑色素瘤细胞的实验中,当5-FC浓度达到1 μmol/ml时,双自杀基因表达系统组中黑色素瘤B16-F10细胞的存活率几乎接近0,该自杀基因表达系统表现出非常好的抗肿瘤效果,而该系统在鼠体内的抑瘤效果,以何种剂量,何种方式给药能达到最好的抑瘤效果,以及此系统的临床实用价值是我们将来所要解决的问题,有待我们进一步的实验验证。
, http://www.100md.com
    参考文献

    [1] 吴瑜,易成,王树人,等.婴儿双歧杆菌对小鼠黑色素瘤模型肿瘤组织的靶向性.四川大学学报(医学版),2003,34(3):435-438.

    [2] Kazuyuki Yazawa,Minoru Fujimori,Jun Amano,et al.Bifidobacterium longum as a delivery system for cancer gene therapy:selective localization and growth in hypoxic tumors.Cancer Gene Ther,2000,7:269-274.

    [3] O’sullivan DJ,Klaenhammer TR.High-and low-copy-number Lactococcus shuttle cloning vectors with features for clone screening.Gene,1993,137:227-231.
, http://www.100md.com
    [4] Alessandra Argnani,Rob J.Leer,Nicole van Luijk,et al.A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium.Microbiology,1996,142:109-114.

    [5] Pinedo HM,Peters GFJ.Fluorouracil:biochemistry and pharmacology.J Clin Oncol,1988,6:1644-1653.

    [6] Breitman ML,Clapoff S,Rossant J,et al.Genetic ablation:targeted expression of a toxin gene causes microphthalmia in transgenic mice.Science,1987,238(4833):1563-1565.
, 百拇医药
    [7] Moulder JE,Rockwell S.Hypoxic fractions of solid tumors:experimental techniques,methods of analysis,and survey of existing data.Int J Radiat Oncol Biol Phys,1984,10:695-712.

    [8] Vaupel PW,Hockel M.Oxygenation status of human tumors:a reappraisal using computerized pO2 histography.Tumor Oxygenation,1994:219-232.

    [9] Vaupel PW.Oxygenation of solid tumors in drug resistance in oncology.Marcel Dekker,1993:53-85.
, 百拇医药
    [10] Palmiter RD,Behringer RR,Quaife CJ,et al.Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene.Cell,1987,50(3):435-443.

    [11] Van der Wilt CL,Pinedo HM,Smid K,et al.Effect of folinic acid on fluorouracil activity and expression of thymidine synthase.Semin Oncol,1992,19:16-25.

    [12] Tiraby M,Cazaux C,Baron M,et al.Concomitant expression of E.coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine.FEMS Microbiol Lett,1998,167(1):41-49.
, 百拇医药
    [13] Adachi Y,Tamiya T,Ichikawa T,et al.Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.Hum Gene Ther,2000,11(1):77-89.

    [14] Koyama F,Sawada H,Hirao T,et al.Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.Cancer Gene Ther,2000,7(7):1015-1022.
, 百拇医药
    [15] Miyagi T,Koshida K,Hori O,et al.Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.J Gene Med,2003,5(1):30-37.

    [16] 安丽娜,李著华,岳扬,等.婴儿双歧杆菌介导的CD和UPRT联合5-FC基因疗法对黑色素瘤的体外治疗实验研究.四川大学学报(医学版),2007,38(1):27-30,63.

    [17] 易成,郭志英,黄英,等.婴儿双歧杆菌介导的CD/5-FC自杀基因系统对黑色素瘤的抑瘤实验.四川大学学报(医学版),2005,36(2):165-168., 百拇医药(叶 鹏 李著华 杨彦彪 王树人)
上一页1 2 3